News-Papers
Testimonial
Video Gallery
Factors in the Production and Growth of tumor Metastases
Published on Wednesday, 19 March 2014
Factors in the Production and Growth of tumor Metastases
Search
Follow us...
Latest
- Radioprotective and Radiomitigative Effects of Melatonin in Tissues with Different Proliferative Activity
- Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)
- Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens
- Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
- The effects of growth hormone on therapy resistance in cancer
- Anti-apoptotic and antioxidant effects of melatonin protect spleen of whole body γ-irradiated male Sprague-dawley rats
- Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Melatonin for the prevention and treatment of cancer
- Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases
- Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells
- Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
- Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids
- Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma
- Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy
- Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
- Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
- Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer